- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04566094
Lung Herniation After Uniportal VATS
March 25, 2025 updated by: Insel Gruppe AG, University Hospital Bern
Lung Herniation After Uniportal VATS. Rarity or Common Finding?
During patient follow up the investigators noticed the occasional occurence of a lung herniation after uniportal Video assisted thoracoscopic surgery (VATS).
Most of These patients were asymptomatic and didn't require any kind of treatment.
To analyse the incidence of postoperative lung herniation after uniportal and the presence of symptoms the investigators decided to review every postoperative CT scan from January 2016 until March 2019 to radiologically identify postoperative lung herniations.
Afterwards the investigators will contact the respective patient to ask for a follow-up physical examination and symptom evaluation (after consent was signed).
Study Overview
Status
Withdrawn
Conditions
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bern, Switzerland, 3007
- Bern University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Every patient submitted to uniportal VATS anatomic lung resection from January 2016 until March 2019 who has had a postoperative radiological follow up.
Description
Inclusion Criteria:
- Anatomical lung resection using uniportal VATS
Exclusion Criteria:
- Non anatomical lung resection
- Open surgery
- Pneumonectomy
- Informed consent not signed
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lung herniation
Time Frame: Postoperative follow-up up to 6 months
|
Presence of intercostal lung herniation after uniportal VATS
|
Postoperative follow-up up to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Symptoms
Time Frame: Postoperative follow-up to 5 years
|
Symptoms described by patients presenting an intercostal lung hernia
|
Postoperative follow-up to 5 years
|
|
Risk factors
Time Frame: At the time of operation
|
Presence of Risk factors associated with the development of intercostal lung hernia after uniportal VATS surgery
|
At the time of operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jon Lutz, MD, Department of General Thoracic Surgery Bern University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
November 1, 2025
Primary Completion (Estimated)
November 1, 2025
Study Completion (Estimated)
December 1, 2025
Study Registration Dates
First Submitted
September 22, 2020
First Submitted That Met QC Criteria
September 22, 2020
First Posted (Actual)
September 28, 2020
Study Record Updates
Last Update Posted (Actual)
March 30, 2025
Last Update Submitted That Met QC Criteria
March 25, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17092020
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.